Banner - NPPA Connect

Pediatric Dermatology

Latest News



Waikoloa, Hawaii - A new foam formulation of the antifungal drug ketoconazole (Extina 2 percent, Connetics Corp.), currently under FDA review, seems to be more completely absorbed into the skin than the same ingredient in other formulations and could be more effective in the treatment of sehorrheic dermatitis, said Linda F. Stein Gold, M.D., director of clinical research, department of dermatology, Henry Ford Health System, West Bloomfield, Mich.

Over the rainbow

Barcelona - In two Phase IV efficacy studies designed to evaluate pimecrolimus 1 percent cream (Elidel?, Novartis Pharmaceuticals Corp.) under "real world" conditions, treatment with pimecrolimus 1 percent cream for up to six months was found to be safe and effective in infants, children, and adults who were suffering from atopic dermatitis with all degrees of severity and who had received a wide variety of previous treatments. Moreover, in both trials, subjects reported improvements in quality of life and a high degree of cosmetic acceptability, according to clinical investigators Lyn C. Guenther, M.D., F.R.C.P.C., Professor of Dermatology at the University of Western Ontario in London, Ontario, Can., and Sheila Fallon Friedlander, M.D., Associate Clinical Professor of Dermatology at Children's Hospital & UCSD Medical Center in San Diego, Calif. Results of both trials were presented at the 12th Congress of the European Academy of Dermatology and Venereology in Barcelona.

Atopic dermatitis duo

Waikoloa, Hawaii - A combination topical treatment regimen consisting of the calcineurin inhibitor tacrolimus 0.1 percent ointment (Protopic, Fujisawa) plus the moderate potency corticosteroid clocortolone pivalate 0.1 percent cream (Cloderm, Healthpoint) is more effective in the treatment of atopic dermatitis and associated with fewer side effects than monotherapy with either agent alone, said Alan B. Fleischer, Jr., M.D., at the annual Hawaii Dermatology Seminar in January.

Sporting skin infection

Cincinnati - With wrestling season well under way, late fall and winter becomes a busy time for a sports dermatology clinic, said Brian B. Adams, M.D.

Bexarotene benefits

Waikoloa, HI - Bexarotene 1 percent gel (Targretin) is a useful alternative modality for the treatment of mycosis fungoides, said Joan Guitart, M.D., at the annual Hawaii Dermatology Seminar.

Detective work

Miami - Dermatologists who ask the right questions when they see children with cutaneous conditions might discover that academic, emotional, or social problems are at the root of some of these skin disorders.

Reassurance

Atlanta - With laser resurfacing on the decline, dermatologists might see more complications with dermabrasion and peels, partly because the sheer number of these procedures is rising. However, other factors are also at play.

Philadelphia - Of all the cosmetic procedures that make hands appear younger, sclerotherapy delivers the most dramatic, long-lasting results, according to Lee Schulman, M.D., a phlebologist at Schulman Vein and Laser Center in New York City.

Craig G. Burkhart, M.P.H., M.D., has a flier for patients in his waiting room in Sylvania, Ohio. It is not your ordinary practice brochure. Rather, his is more personal. It features a series of pictures that a Toledo Blade newspaper photographer took of Dr. Burkhart when the dermatologist was 2 1/2 years old. It was his first haircut, and the photo was taken at the barbershop. The series starts with a picture of the toddler crying because he was about to lose his cute, curly locks. The pictures go on to show the range of emotions, with the last photo

Barcelona, Spain - Identifying the cause of itch is the key to treating it. New research is helping better characterize pruritus, leading to more effective therapies for this frustrating condition, according to physicians reporting at the 2003 meeting of the European Academy of Dermatology and Venereology (EADV).

Barcelona, Spain - New research demonstrates the pathophysiology of itch may be more complex than once believed. Recently discovered pruritic pathways, such as those involving proteases or neuropeptides, are opening doors to new therapeutic targets for this uncomfortable, hard-to-control phenomenon.

Baltimore - PUVA and phototherapy are safe and effective for the treatment of more than two dozen conditions, but of the dermatologists who provide these treatments, as many as half use them solely for psoriasis, according to Warwick L. Morison M.D., professor of dermatology, Johns Hopkins Medical School, Baltimore.

Washington, D.C. - Tacrolimus and pimecrolimus may spring to mind first when atopic dermatitis is diagnosed, but it turns out that these topical immunomodulators are also effective for a host of previously difficult-to-treat diseases. Granuloma faciale, Hailey Hailey disease, hand and foot eczema and chromic actinic dermatitis are among the lengthy list of conditions these work well for, according to Mark Lebwohl, M.D., Professor and Chairman, Department of Dermatology, Mt. Sinai School of Medicine.

Topical treatment tips

Detroit - Topical treatment allows medication delivery directly to the skin with reduced systemic exposure compared to orally administered agents, but local drug application is not without risk to internal organ systems, according to Peter J. Aronson, M.D.

Montreal - Diagnosing unusual sexually transmitted infections can be a unique challenge, particularly for physicians lacking expertise in this area.

San Diego - With careful use, smallpox vaccination programs can be implemented on a large scale, and dermatologists will play a big role in its execution by assisting local health departments and preparing their professional colleagues, according to information presented by Colonel John D. Grabenstein, R.Ph., Ph.D., at the recent Infectious Diseases Society of America's annual meeting, held here.

Washington, D.C. - Responding to concerns over increased malignancies seen in animal studies, a pediatric subcommittee of the FDA's Anti-Infective Drugs Advisory Committee said topical immunosuppressant labeling should include a warning against use in children under the age of two.

Transplants, Cancer Link

New Orleans -A research collaboration between members of the International Transplant-Skin Cancer Collaborative (ITSCC) and the United Network for Organ Sharing (UNOS) is yielding some important new information about skin cancer in organ transplant recipients and demonstrates the value of the UNOS database as a rich and reliable public resource for investigating issues relating to those patients, said Clark C. Otley, M.D.